Francesca Fieni
Founder and CSO at Pano Therapeutics.
Francesca Fieni, PharmD, PhD, is the founder and CSO of Pano Therapeutics, a platform biotech company she spun out of UCSF focused on clinical development of drugs targeting mitochondrial ion channels to address complex diseases of aging and extend health span. Francesca earned a PharmD and a PhD in Neuroscience from the University of Modena and Reggio Emilia, Italy and subsequently pursued a postdoctoral fellowship at Massachusetts General Hospital, Harvard Medical School in Boston. She was an independent research associate/specialist at the University of California San Francisco before she turned entrepreneur.
Visit website: https://www.panotherapeutics.com/team
See also
Pano Therapeutics
Addressing complex diseases of aging by targeting mitochondrial ion channels and transporters.
Details last updated 07-Jan-2021
Francesca Fieni is also referenced in the following:
Metabesity 2021
11-Oct-2021 to 14-Oct-2021
The Kitalys institute virtual conference targeting key questions that will impact the future of aging and extending healthspan
Mitochondria, Aging, and Health
08-Jan-2021
Speakers are Douglas Wallace, Francesca Fieni, Hazel Szeto and Michael Zemel